Denali Therapeutics Inc.
Kinase Inhibitors and Uses Thereof
Last updated:
Abstract:
The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.
Status:
Application
Type:
Utility
Filling date:
26 Oct 2021
Issue date:
10 Feb 2022